
vSpring Capital
Description
Signal Peak Ventures, formerly known as vSpring Capital, is a prominent early-stage venture capital firm based in Salt Lake City, Utah. The firm underwent a rebranding from vSpring Capital to Signal Peak Ventures, signifying its evolution and continued commitment to fostering innovation in the technology sector. With a robust financial backing, Signal Peak Ventures manages over $700 million in committed capital across four distinct funds, positioning it as a significant player in the early-stage investment landscape.
The firm primarily focuses on investing in technology companies during their Seed, Series A, and Series B funding rounds. Their investment thesis centers on disruptive B2B software, including enterprise SaaS, cloud infrastructure, data analytics, artificial intelligence/machine learning, and cybersecurity solutions. While they maintain a strong presence and focus on the Intermountain West region, Signal Peak Ventures also actively seeks out promising opportunities across the broader United States, demonstrating a national reach in their investment strategy.
Signal Peak Ventures is known for its hands-on approach, providing not just capital but also strategic guidance and operational support to its portfolio companies. Their typical initial investment in a company ranges from $2 million to $10 million, indicating a preference for substantial early-stage commitments that can significantly fuel growth and product development. Over its history, including its time as vSpring Capital, the firm has built an impressive portfolio, having invested in more than 70 companies, many of which have gone on to achieve significant success and exits. This track record underscores their expertise in identifying and nurturing high-potential technology ventures.
Investor Profile
vSpring Capital has backed more than 65 startups, with 0 new investments in the last 12 months alone. The firm has led 21 rounds, about 32% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Typical check size: $2M – $10M.
Stage Focus
- Series B (38%)
- Series A (32%)
- Series Unknown (11%)
- Series C (8%)
- Series D (3%)
- Seed (3%)
- Angel (2%)
- Series F (2%)
- Series E (2%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Medical
- Genetics
- Consumer Electronics
- Energy Management
- Smart Home
- Health Diagnostics
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.